Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1997 | 09-1997 | 06-1997 | 03-1997 | 12-1996 | |
| Sales | 750 | 5,360 | 3,550 | 8,260 | 3,590 |
| Cost of Goods | 5,050 | 4,930 | 3,390 | 4,270 | 7,560 |
| Gross Profit | -4,300 | 430 | 160 | 3,990 | -3,970 |
| Operating Expenses | 720 | 0 | 0 | 0 | 660 |
| Operating Income | -5,020 | 430 | 160 | 3,990 | -4,630 |
| Interest Expense | 0 | 0 | 10 | 0 | 0 |
| Other Income | -4,450 | -2,250 | -2,080 | -2,270 | -3,049 |
| Pre-tax Income | -9,470 | -1,820 | -1,930 | 1,720 | -7,679 |
| Income Tax | -1,560 | 0 | 0 | 0 | -1,850 |
| Net Income Continuous | -7,910 | -1,820 | -1,930 | 1,720 | -5,829 |
| Net Income | $-8,270 | $-1,500 | $-1,590 | $1,420 | $-6,397 |
| EBITDA(a) | $-5,020 | $430 | $160 | $3,990 | $-4,630 |